Edesa Biotech
EDSA
12 hedge funds and large institutions have $430K invested in Edesa Biotech in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
505% more capital invested
Capital invested by funds: $71.1K → $430K (+$359K)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
20% more funds holding
Funds holding: 10 → 12 (+2)
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$333K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$53.6K |
| 3 |
CB
Chemical Bank
Detroit,
Michigan
|
+$27.1K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$1.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.12K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2K |
| 3 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $300K | +$333K | +627 | New |
|
|
VKH
2
Virtu KCG Holdings
New York
| $49K | +$53.6K | +101 | New |
|
|
AG
3
Advisor Group
Phoenix,
Arizona
| $43K | +$1.06K | +2 | +2% |
|
|
CB
4
Chemical Bank
Detroit,
Michigan
| $24K | +$27.1K | +51 | New |
|
|
WAS
5
WESPAC Advisors SoCal
Pasadena,
California
| $3.26K | – | – | – |
|
6
Creative Planning
Overland Park,
Kansas
| $3K | – | – | – |
|
|
CFD
7
Creative Financial Designs
Kokomo,
Indiana
| $2K | – | – | – |
|
|
WP
8
WealthPLAN Partners
Omaha,
Nebraska
| $1.46K | +$1.59K | +3 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
EDRH
10
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $1K | – | – | – |
|
|
LTFS
11
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
ASN
12
Advisory Services Network
Atlanta,
Georgia
| $1K | +$1.59K | +3 | New |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$2.12K | -4 | Closed |
|
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -3 | Closed |
|
|
WAM
15
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | -$1K | -2 | Closed |
|
EDSA Hedge Fund Activity: Q1 2017 in Review
12 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2017, worth a combined $430K — up 505% from $71.1K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new EDSA positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $333K. The largest seller was UBS Group, exiting entirely with an estimated $2.12K sold.
- 12 institutional investors held Edesa Biotech (EDSA) as of Q1 2017, up from 10 in Q4 2016.
- Funds reported $430K of Edesa Biotech stock for Q1 2017, up 505% quarter-over-quarter.
- 5 funds opened new Edesa Biotech positions in Q1 2017 and 3 closed out, a net change of +2 holders.
- The largest Edesa Biotech buyer in Q1 2017 was Anson Funds Management, an estimated $333K added.
- The largest Edesa Biotech seller in Q1 2017 was UBS Group, an estimated $2.12K sold.
Based on aggregated 13F filings for Q1 2017.